Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

AZASITE

AZITHROMYCIN

Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview AZASITE is listed in Drugs@FDA under application 050810 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient AZITHROMYCIN Form and strength SOLUTION/DROPS;OPHTHALMIC - 1% Sponsor THEA PHARMA Submission history Latest submission status date: 2024-07-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview AZASITE is listed in Drugs@FDA under application 050810 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AZITHROMYCIN Form and strength SOLUTION/DROPS;OPHTHALMIC - 1% Sponsor THEA PHARMA Submission history Latest submission status date: 2024-07-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.